Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 39 articles:
HTML format
Text format



Single Articles


    March 2017
  1. ZHAI Z, Liu W, Kaur M, Luo Y, et al
    NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma.
    Oncogene. 2017 Mar 6. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  2. YANG H, Kircher DA, Kim KH, Grossmann AH, et al
    Activated MEK cooperates with Cdkn2a and Pten loss to promote the development and maintenance of melanoma.
    Oncogene. 2017 Mar 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    February 2017
  3. LUO S, Li Y, Ma R, Liu J, et al
    Downregulation of PCK2 remodels tricarboxylic acid cycle in tumor-repopulating cells of melanoma.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2017
  4. BROWN K, Yang P, Salvador D, Kulikauskas R, et al
    WNT/beta-catenin signaling regulates mitochondrial activity to alter the oncogenic potential of melanoma in a PTEN-dependent manner.
    Oncogene. 2017 Jan 16. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  5. WORRALL C, Suleymanova N, Crudden C, Trocoli Drakensjo I, et al
    Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma.
    Oncogene. 2017 Jan 16. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  6. DELYON J, Servy A, Laugier F, Andre J, et al
    PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma.
    Oncogene. 2017 Jan 16. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  7. KIM HS, Jung M, Kang HN, Kim H, et al
    Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition.
    Oncogene. 2017 Jan 16. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  8. RIVERSO M, Montagnani V, Stecca B
    KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth.
    Oncogene. 2017 Jan 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    November 2016
  9. WANG Y, Ou Z, Sun Y, Yeh S, et al
    Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals.
    Oncogene. 2016 Nov 21. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    October 2016
  10. FAIAO-FLORES F, Alves-Fernandes DK, Pennacchi PC, Sandri S, et al
    Targeting the hedgehog transcription factors GLI1 and GLI2 restores sensitivity to vemurafenib-resistant human melanoma cells.
    Oncogene. 2016 Oct 17. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    July 2016
  11. AGAESSE G, Barbollat-Boutrand L, Sulpice E, Bhajun R, et al
    A large-scale RNAi screen identifies LCMR1 as a critical regulator of Tspan8-mediated melanoma invasion.
    Oncogene. 2016 Jul 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    June 2016
  12. JIANG CC, Croft A, Tseng HY, Guo ST, et al
    Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma.
    Oncogene. 2016 Jun 27. doi: 10.1038/onc.2016.
    PubMed     Text format    


  13. RATNIKOV BI, Scott DA, Osterman AL, Smith JW, et al
    Metabolic rewiring in melanoma.
    Oncogene. 2016 Jun 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    May 2016
  14. DE DONATIS GM, Le Pape E, Pierron A, Cheli Y, et al
    NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2.
    Oncogene. 2016;35:2813.
    PubMed     Text format    


    April 2016
  15. ZHANG P, Feng S, Liu G, Wang H, et al
    CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    March 2016
  16. PENG C, Zeng W, Su J, Kuang Y, et al
    Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway.
    Oncogene. 2016;35:1170-9.
    PubMed     Text format     Abstract available


    January 2016
  17. ASCHACHER T, Wolf B, Enzmann F, Kienzl P, et al
    LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines.
    Oncogene. 2016;35:94-104.
    PubMed     Text format     Abstract available


    October 2015
  18. MUKHOPADHYAY P, Ferguson B, Muller HK, Handoko HY, et al
    Murine melanomas accelerated by a single UVR exposure carry photoproduct footprints but lack UV signature C>T mutations in critical genes.
    Oncogene. 2015 Oct 19. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  19. KALE S, Raja R, Thorat D, Soundararajan G, et al
    Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via alpha9beta1 integrin.
    Oncogene. 2015;34:5408-10.
    PubMed     Text format    


  20. FELLI N, Errico MC, Pedini F, Petrini M, et al
    AP2alpha controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression.
    Oncogene. 2015 Oct 5. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    September 2015
  21. PEROTTI V, Baldassari P, Molla A, Vegetti C, et al
    NFATc2 is an intrinsic regulator of melanoma dedifferentiation.
    Oncogene. 2015 Sep 21. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  22. DE DONATIS GM, Pape EL, Pierron A, Cheli Y, et al
    NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2.
    Oncogene. 2015 Sep 14. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    August 2015
  23. KRUISWIJK F, Hasenfuss SC, Sivapatham R, Baar MP, et al
    Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling.
    Oncogene. 2015 Aug 17. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    July 2015
  24. MATHSYARAJA H, Thies K, Taffany DA, Deighan C, et al
    CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth.
    Oncogene. 2015;34:3651-61.
    PubMed     Text format     Abstract available


    June 2015
  25. FLASHNER-ABRAMSON E, Klein S, Mullin G, Shoshan E, et al
    Targeting melanoma with NT157 by blocking Stat3 and IGF1R signaling.
    Oncogene. 2015 Jun 29. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  26. FEDORENKO IV, Abel EV, Koomen JM, Fang B, et al
    Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells.
    Oncogene. 2015 Jun 15. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  27. KURIYAMA S, Yoshida M, Yano S, Aiba N, et al
    LPP inhibits collective cell migration during lung cancer dissemination.
    Oncogene. 2015 Jun 1. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    April 2015
  28. ZHAO T, Du H, Ding X, Walls K, et al
    Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis in lal(-/-) mice.
    Oncogene. 2015;34:1938-48.
    PubMed     Text format     Abstract available


    March 2015
  29. YANG Y, Gorzelanny C, Bauer AT, Halter N, et al
    Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity.
    Oncogene. 2015 Mar 9. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  30. WANG J, Tang X, Weng W, Qiao Y, et al
    The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma.
    Oncogene. 2015 Mar 2. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  31. LAU E, Sedy J, Sander C, Shaw MA, et al
    Transcriptional repression of IFNbeta1 by ATF2 confers melanoma resistance to therapy.
    Oncogene. 2015 Mar 2. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    February 2015
  32. SERASINGHE MN, Missert DJ, Asciolla JJ, Podgrabinska S, et al
    Anti-apoptotic BCL-2 proteins govern cellular outcome following B-RAF(V600E) inhibition and can be targeted to reduce resistance.
    Oncogene. 2015;34:857-67.
    PubMed     Text format     Abstract available


    January 2015
  33. MENON DR, Das S, Krepler C, Vultur A, et al
    A stress-induced early innate response causes multidrug tolerance in melanoma.
    Oncogene. 2015 Jan 26. doi: 10.1038/onc.2014.
    PubMed     Text format    


  34. DONG H, Tian L, Li R, Pei C, et al
    IFNg-induced Irgm1 promotes tumorigenesis of melanoma via dual regulation of apoptosis and Bif-1-dependent autophagy.
    Oncogene. 2015 Jan 26. doi: 10.1038/onc.2014.
    PubMed     Text format     Abstract available


    December 2014
  35. KUBIC JD, Little EC, Lui JW, Iizuka T, et al
    PAX3 and ETS1 synergistically activate MET expression in melanoma cells.
    Oncogene. 2014 Dec 22. doi: 10.1038/onc.2014.
    PubMed     Text format     Abstract available


    November 2014
  36. RAVINDRAN MENON D, Das S, Krepler C, Vultur A, et al
    A stress-induced early innate response causes multidrug tolerance in melanoma.
    Oncogene. 2014 Nov 24. doi: 10.1038/onc.2014.
    PubMed     Text format     Abstract available


  37. MANNING CS, Hooper S, Sahai EA
    Intravital imaging of SRF and Notch signalling identifies a key role for EZH2 in invasive melanoma cells.
    Oncogene. 2014;0.
    PubMed     Text format     Abstract available


    October 2014
  38. TAN M, Li H, Sun Y
    Endothelial deletion of Sag/Rbx2/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis.
    Oncogene. 2014;33:5211-20.
    PubMed     Text format     Abstract available


    November 2013
  39. XU C , Lin L, Cao G, Chen Q, et al
    Interferon-alpha-secreting mesenchymal stem cells exert potent antitumor effect in vivo.
    Oncogene. 2013 Nov 4. doi: 10.1038/onc.2013.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: